Open AccessThis article is
- freely available
Prognostic Significance of Melanoma Differentiation and Trans-Differentiation
Department of Dermatology, University of Wisconsin School of Medicine and Public Health, 1300 University Avenue, B25, Madison WI 53706, USA
* Author to whom correspondence should be addressed.
Received: 2 March 2010; in revised form: 13 April 2010 / Accepted: 18 May 2010 / Published: 26 May 2010
Abstract: Cutaneous malignant melanomas share a number of molecular attributes such as limitless replicative potential that define capabilities acquired by most malignancies. Accordingly, much effort has been focused on evaluating and validating protein markers related to these capabilities to function as melanoma prognostic markers. However, a few studies have also highlighted the prognostic value of markers that define melanocytic differentiation and the plasticity of melanoma cells to trans-differentiate along several other cellular pathways. Here, we provide a comprehensive review and evaluation of the prognostic significance of melanocyte-lineage markers such as MITF and melanogenic proteins, as well as markers of vascular epithelial and neuronal differentiation.
Keywords: melanoma; melanocyte; prognostic markers; differentiation; trans-differentiation
Citations to this Article
Cite This Article
MDPI and ACS Style
Maddodi, N.; Setaluri, V. Prognostic Significance of Melanoma Differentiation and Trans-Differentiation. Cancers 2010, 2, 989-999.
Maddodi N, Setaluri V. Prognostic Significance of Melanoma Differentiation and Trans-Differentiation. Cancers. 2010; 2(2):989-999.
Maddodi, Nityanand; Setaluri, Vijayasaradhi. 2010. "Prognostic Significance of Melanoma Differentiation and Trans-Differentiation." Cancers 2, no. 2: 989-999.